Purposefully phase out cigarettes

Our intention is not only to develop, scientifically substantiate, and responsibly commercialize smoke-free products to offer a better alternative to adult smokers, but also to make sure these products ultimately, and as soon as possible, replace cigarettes completely.

 

 

phase out cigarettes roadmap

Our 2025 Roadmap goal

See our full 2025 roadmap

PURPOSEFULLY PHASE OUT CIGARETTES

Our intention is not only to develop, scientifically substantiate, and responsibly commercialize smoke-free products to offer a better alternative to adult smokers, but also to make sure these products ultimately, and as soon as possible, replace cigarettes completely.

Key performance indicators to track our progress

Intentionally work toward phasing out cigarettes by ensuring that we become a substantially smoke-free company by net revenues by 2030 and continue to reduce our combustible shipment volume

Smoke-free products represented 36.4 percent of our annual net revenues in 2023 (2022: 32.1 percent),* and 18.6 percent of our total shipment volume (2022: 15.1 percent).** Meanwhile our combustible tobacco product shipment volume decreased by 27.9 percent versus 2015.

*For definition of net revenues related to smoke-free products, see Glossary. Data excludes the impact related to termination of distribution arrangement in the Middle East in 202.
** These indicators are calculated based on millions of units. For definition of smoke-free products and combustible tobacco products, see Glossary. Smoke-free products shipment volume includes volume of smoke-free products that can be converted into cigarette equivalent units, such as heat-not-burn, e-vapor, and oral nicotine. Total shipment volume includes the listed smoke-free products as well as combustible tobacco products: cigarettes and other tobacco products expressed in cigarette equivalent units. Data does not include wellness and healthcare products

fundamentals background

See full performance metrics

view data

Learn more about PMI’s Sustainability Index in our Integrated Report 2023. See the full performance metrics and related footnotes here.

THE RIGHT THING TO DO

Even though selling off our cigarette business would make our Company achieve its smoke-free ambition faster, it would not resolve the cigarette problem—and indeed would risk exacerbating the issue as a new owner would more likely be focused on maximizing cigarette consumption.

Read more

The right thing to do

Even though selling off our cigarette business would make our Company achieve its smoke-free ambition faster, it would not resolve the cigarette problem—and indeed would risk exacerbating the issue as a new owner would more likely be focused on maximizing cigarette consumption.

Our aim is not only to make our Company smoke-free, but also to make cigarettes obsolete. To achieve this, we will continue to responsibly sell cigarettes, taking a consistent, disciplined, and steadfast approach to one day completely leaving them behind.

While perhaps contradictory in the eyes of some stakeholders, this is a necessary trade-off that is vital to driving a successful industry transition for the benefit of public health.

We are convinced that impactful and systemic change can best be achieved by transforming from the inside out, engaging constructively with different parts of society, and ultimately influencing our entire industry to follow our lead and adopt business models that also seek to completely replace cigarettes with smoke-free products for those who continue to use nicotine.

THE BUSINESS CASE

Despite being well on our way to delivering a smoke-free future, we still have some distance to travel, as our combustible tobacco product business still represents the majority of our revenues. The operating cash flows generated by cigarettes serve an essential role, supporting ongoing investments to drive the growth of smoke-free products and in building new capabilities in wellness and healthcare.

Read more

The business case

Despite being well on our way to delivering a smoke-free future, we still have some distance to travel, as our combustible tobacco product business still represents the majority of our revenues. The operating cash flows generated by cigarettes serve an essential role, supporting ongoing investments to drive the growth of smoke-free products and in building new capabilities in wellness and healthcare.

Staying competitive in the cigarette category during this interim period provides the infrastructure needed to support our smoke-free growth, allowing us to create a future where cigarettes no longer exist. Notably, where permitted, it remains the primary way we can engage and connect with adult smokers and trade partners to raise awareness of smoke-free products and explain why they are a better option than continued smoking. Exiting the cigarette category and therefore ceding market share to competitors is unlikely to provide them with strong motivation to follow our smoke-free lead.

Our legitimate ambition to maintain market share in the declining combustible tobacco product category does not mean that we aim to continue selling cigarettes in the long term. Our purpose is clear: our smoke-free business is our focus area of growth, as these are the products needed to enable our transformation and, most importantly, to help make cigarettes obsolete.

Smoke-free products offer the prospect of higher and more sustainable returns than cigarettes over the long term, as reflected in the premium observed in our equity valuation multiples relative to the majority of our cigarette-focused peers. The business case is clear, with compelling financial incentives for us to transform as fast as possible.

phase out cigarettes roadmap

Our progress in 2023

Read more in our Integrated Report
Related articles, case studies, and videos
Maximize benefit smoke-free products article highlight

Maximize the benefits of smoke-free products

read more
JPG-800width-PMI Science Cube

Business Transformation Metrics

read more
Related reports, policies, and documents

Sustainability KPI protocol 2023

Download


Looking ahead

While cigarette sales today remain the largest part of PMI’s business in most countries, this is changing rapidly. PMI is actively accelerating the decline in cigarette smoking beyond what traditional tobacco control measures can achieve alone. It is important to note, however, that no phase-out plan will work unless phase-out policies and regulations take a comprehensive approach to driving commensurate reductions in demand for cigarettes. This should include measures to ensure fewer people initiate smoking, more people quit smoking, and those who don't quit are encouraged to switch away from cigarettes to better, smoke-free products. We believe that with the right kind of policies and regulations, many countries could soon be on the verge of beginning the phase-out of cigarettes altogether. While PMI has a vital role to play in accelerating the transition from cigarettes to smoke-free alternatives, we cannot achieve this objective alone. We will continue to engage with our industry peers, the tobacco control community, policymakers, and all relevant stakeholders with an interest in bringing about the end of smoking.

Industry disruption only looks easy in hindsight. At present, we are in mid-stride: with one foot in our past, operating in a fiercely competitive legacy cigarette business, and one foot in our bold future, building an entirely novel and improved category of products. We recognize the magnitude of the challenge and remain committed to continuing to lead, track progress, and report on it transparently to ensure that cigarettes become obsolete as soon as possible.

Cigarettes continue to represent a sizeable portion of our volumes and an opportunity to engage with adult smokers around better alternatives than smoking. We are committed to selling them responsibly while transitioning to smoke-free products. We will continue implementing our youth access prevention efforts globally and investigate ways of continuing to strengthen their enforcement.

This online content about our Integrated Report should be read in conjunction with PMI’s Integrated Report 2023. This report includes metrics that are subject to measurement uncertainties due to inherent limitations in the nature and methods for data collection and measurement. The precision of different collection and measurement techniques may also vary. This report includes data or information obtained from external sources or third parties. Unless otherwise indicated, the data contained herein cover our operations worldwide for the full calendar year 2023 or reflect the status as of December 31, 2023. Where not specified, data comes from PMI financials, nonfinancials, or estimates. Unless explicitly stated, the data, information, and aspirations referenced in online content do not incorporate PMI’s wellness and healthcare business, Vectura Fertin Pharma. Regarding the Swedish Match acquisition, completed late 2022, unless otherwise indicated, online content does not include information pertaining to their sustainability performance. Please also refer to "This report at a glance" on page 2 of the PMI Integrated Report 2023 for more information. Aspirational targets and goals do not constitute financial projections, and achievement of future results is subject to risks, uncertainties and inaccurate assumptions, as outlined in our forward-looking and cautionary statements on page 214. In PMI's Integrated Report 2023 and in related communications, the terms “materiality,” “material,” and similar terms are defined in the referenced sustainability standards and are not meant to correspond to the concept of materiality under the U.S. securities laws and/or disclosures required by the U.S. Securities and Exchange Commission.

 

Share this page